Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone in Subclinical Cushing's Syndrome
NCT00721201Phase 2
Key facts
- Status
- Completed
- Start
- Nov 2008
- Primary completion
- Mar 2010
- Countries
- 1
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Modality
- Orthosteric Ligands
- Drugs
- mifepristone
- Conditions
- Cushing's syndrome
01
Overview
Phase 2, open-label trial of mifepristone in Cushing's syndrome, sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Primary endpoint: Blood pressure at 8 weeks. Started Nov 2008; status: completed.
02
Design
- Study design
- Non-randomizedOpen-labelSingle group
03
Endpoints
Primary
Blood pressure
Secondary
Glucose homeostasis
Beyond the preview
Go deeper on NCT00721201.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00721201.